![NATA](https://nata.com.au/files/2021/02/nata.png)
National Association of Testing Authorities, Australia
Scope of Accreditation
Microbiological Diagnostic Unit, Public Health Laboratory - University of Melbourne
Site
The University of Melbourne – At the Peter Doherty Institute for Infection & Immunity
Accreditation No.
1019
Site No.
1012
Date of Accreditation
07 Sep 1972
Address
Department of Microbiology and Immunology, At the Peter Doherty Institute for Infection and Immunity, Level 1, 792 Elizabeth St (cnr of Grattan and Elizabeth St)
Melbourne, VIC 3000
Australia
Contact
Availability
Services conditionally available to external clients
Supervision
Scientist Supervised Laboratory
Scope of Accreditation
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Antibiotic sensitivity (susceptibility) testing | Bacterial isolates; Fungal isolates | Minimum inhibitory concentration (MIC) | Microbroth dilution | in-house method ENS053 |
Detection and identification of bacteria | Bacterial isolates | Bacillus anthracis; Bacillus cereus; Brucella spp.; Burkholderia pseudomallei; Campylobacter coli; Campylobacter fetus ss. fetus; Campylobacter fetus ss. venerealis (Cfv); Campylobacter fetus; Campylobacter hyointestinalis; Campylobacter jejuni; Campylobacter spp.; Clostridioides difficile; Clostridium botulinum; Clostridium difficile toxin B; Corynebacterium spp.; Escherichia coli - Haemolytic; Escherichia coli - Non-haemolytic; Escherichia coli K99; Escherichia coli serotyping; Escherichia coli; Francisella tularensis; Nocardia spp.; Rhodococcus equi; Salmonella enterica serovar Typhimurium; Salmonella enterica serovar Gallinarum biovar Pullorum; Salmonella spp.; Salmonella serotype; Vibrio alginolyticus; Vibrio cholerae; Vibrio furnissii; Vibrio harveyi; Vibrio jasicida; Vibrio mimicus; Vibrio ordalii; Vibrio owensii; Vibrio parahaemolyticus; Vibrio penaeicida; Vibrio proteolyticus; Vibrio rotiferianus; Vibrio salmonicida; Vibrio splendidus; Vibrio spp.; Vibrio tapetis; Vibrio tasmaniaensis; Vibrio tubiashii; Yersinia enterocolitica; Yersinia intermedia; Yersinia kristensenii; Yersinia pseudotuberculosis; Yersinia ruckeri; Yersinia spp.; Aerobic spore forming gram positive bacilli; Identification of unknown bacteria | Biochemical; Cultural; Microscopic examination | in-house methods CAS002, CRS001, ECS001, ENS003, ENS032, ENS033, RFS002, RFS017, RFS018, RFS019, RFS021, RFS022, RFS023 and RFS024 |
Identification of unknown bacteria | Sequencing | in-house method MMS012 | ||
Identification of unknown bacteria | MALDI-TOF | in-house method MSS001 software version V3.2 | ||
Bacillus anthracis; Burkholderia pseudomallei; Clostridium botulinum; Escherichia coli - Enterotoxigenic (ETEC); Escherichia coli - Shiga toxin-producing (STEC); Escherichia coli; Escherichia coli O111; Escherichia coli O157; Escherichia coli O26; Escherichia coli uspA; Listeria monocytogenes; Salmonella spp.; Shigella spp.; Staphylococcus aureus; Staphylococcus aureus (including MRSA) Panton-Valentine leukcocidin (PVL) gene; Yersinia spp. | Polymerase chain reaction (PCR) | in-house methods MMS058, MMS078, MMS035, MMS015, and MMS085 | ||
Salmonella enterica serovar Typhimurium; Salmonella enterica serovar Enteritidis; Salmonella enterica serovar Hadar; Salmonella enterica serovar Paratyphi A; Salmonella enterica serovar Paratyphi B; Salmonella enterica serovar Virchow | Serotyping; Serum agglutination | in-house methods ENS005 | ||
Enrichment broth; Faeces | Escherichia coli stx gene | Polymerase chain reaction (PCR) | in-house method MMS035 | |
Faeces | Actinomyces pyogenes; Aeromonas spp.; Bacillus anthracis; Bacillus cereus; Campylobacter coli; Campylobacter fetus ss. fetus; Campylobacter fetus ss. venerealis (Cfv); Campylobacter fetus; Campylobacter hyointestinalis; Campylobacter jejuni; Campylobacter spp.; Clostridioides difficile; Clostridium difficile toxin B; Clostridium perfringens; Escherichia coli - Shiga toxin-producing (STEC); Escherichia spp.; Listeria monocytogenes; Listeria spp.; Plesiomonas spp.; Salmonella enterica serovar Typhimurium; Salmonella enterica serovar Gallinarum biovar Pullorum; Salmonella spp.; Salmonella serotype; Shigella spp.; Staphylococcus aureus; Vibrio cholerae; Vibrio spp.; Yersinia enterocolitica; Coliforms; Enteric bacteria; Identification of unknown bacteria | Biochemical; Cultural; Microscopic examination; Staining | in-house methods BFS002, BFS005, BFS006, BFS007, BFS008, BFS009, BFS010, BFS011, BFS012, BFS013, BFS014, BFS015, BFS019, BFS020, BFS026, BFS027, BFS050, BFS051, BFS052 and BFS053 | |
Detection and identification of parasites and arthropods | Faeces | Cryptosporidium spp.; Giardia spp. | Immunochromatography | in-house method BFS022 (RIDA®QUICK Cryptosporidium/Giardia Combi Test immunochromatographic rapid assay) |
Cryptosporidium hominis; Cryptosporidium parvum; Cryptosporidium spp. | Polymerase chain reaction (PCR) | in-house method MMS023 | ||
Legal management - Forensic operations module | Materials defined by all or some for which the site is accredited | Case record review; Chain of custody; Control of records; Court testimony monitoring; Sample/evidence integrity; Security and access | ||
Molecular analysis - Bioinformatic analysis and interpretation | Bacterial isolates | Single nucleotide polymorphism (SNP) interpretation | Bioinformatics pipeline | In-house method MMS147 |
Molecular analysis - Extraction | Bacterial isolates | Viable DNA for sequencing | Pulse field gel electrophoresis | in-house method MMS109 |
Molecular analysis - Sequencing | Bacterial isolates | Allele typing; Sanger sequencing | Multilocus sequence typing (MLST) | in-house method MMS109 |
Listeria monocytogenes serotyping | Whole genome sequencing | in-house method MMS126 | ||
Single nucleotide polymorphism (SNP) detection | Whole genome sequencing | In-house method MMS147 | ||
Antimicrobial resistance genes | Whole genome sequencing | In-house method MMS118 | ||
Antimicrobial resistance gene, mutation detection and inference of resistance | Whole genome sequencing | in-house method MMS184 | ||
Salmonella spp. serotyping | Whole genome sequencing | In-house method MMS136 | ||
Massively parallel sequencing (MPS) | Massively parallel sequencing (MPS) | in-house method MMS103 | ||
Sanger sequencing | Sanger sequencing | in-house methods MMS012 and MMS023 | ||
Escherichia coli serotyping | Whole genome sequencing | In-house method MMS130 |
ISO/IEC 17025 (2017)
Environment
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Analysis for microorganisms | Air - Ambient; Air - Confined spaces; Air - Indoor; Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Potable waters; Powder of unknown composition; Purified and processed waters; Soils; Surfaces; Swimming pool and spa waters | Ricin | Immunochromatography | in-house method CRS007 |
Air - Ambient; Air - Confined spaces; Air - Indoor; Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Potable waters; Purified and processed waters; Soils; Swimming pool and spa waters | Clostridium botulinum; Clostridium botulinum toxin | Bioassay - Mouse; Cultural; MALDI-TOF; Qualitative selective enrichment | in-house methods RFS017 | |
Clostridium botulinum; Clostridium botulinum toxin | Cultural; Membrane filter; Qualitative selective enrichment | in-house methods FDS025; in-house method WTS013F | ||
Air - Ambient; Air - Confined spaces; Air - Indoor; Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Potable waters; Purified and processed waters; Surfaces; Swimming pool and spa waters | Listeria spp. | Spread plate | in-house method FDS038 and WTS007 | |
Air - Ambient; Air - Confined spaces; Air - Indoor; Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Purified and processed waters; Soils; Swimming pool and spa waters | Clostridium botulinum; Clostridium botulinum toxin | Polymerase chain reaction (PCR) | in-house method MMS058 | |
Air - Ambient; Air - Confined spaces; Air - Indoor; Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Purified and processed waters; Surfaces; Swimming pool and spa waters | Salmonella spp.; Yersinia spp. | Qualitative selective enrichment | in-house methods ENS032 (biochemical); FDS036, WTS009 and FDS029 | |
Bacillus anthracis; Clostridium botulinum; Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145; Escherichia coli; Escherichia coli O157; Listeria spp. | Most probable number (MPN); Qualitative selective enrichment | in-house methods FDS004 (MPN), FDS004M, FDS006E, FDS025, FDS031, FDS037 and WTS003 (MPN) | ||
Air - Ambient; Air - Confined spaces; Air - Indoor; Potable waters; Surfaces | Listeria spp.; Salmonella spp. | Enzyme linked immunosorbent assay (ELISA) - Automated (VIDAS) | in-house method FDS045 and FDS040 | |
Air - Ambient; Air - Confined spaces; Air - Indoor; Surfaces | Escherichia coli | Most probable number (MPN) | in-house method FDS004 | |
Bacterial isolates | Identification | MALDI-TOF | in-house method MSS001, software version V3.2 | |
Bacterial isolates; Soils | Bacillus anthracis; Bacillus anthracis virulence factor genes | Polymerase chain reaction (PCR) | in-house methods MMS025 and MMS058 | |
Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Potable waters; Purified and processed waters; Surfaces; Swimming pool and spa waters | Listeria spp.; Salmonella spp. | Enzyme linked immunosorbent assay (ELISA) - Automated (VIDAS) | in-house methods FDS045 and FDS040 | |
Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Potable waters; Purified and processed waters; Swimming pool and spa waters | Legionella bozemanii; Legionella dumoffi; Legionella gormanii; Legionella jordanis; Legionella longbeachae; Legionella micdadei; Legionella pneumophila; Legionella spp. | Latex agglutination; Spread plate | in-house methods WLS001 and WLS003 | |
Vibrio cholerae; Vibrio parahaemolyticus; Vibrio spp.; Vibrio vulnificus | Qualitative selective enrichment; Slide agglutination | in-house methods ENS033 and WTS008 (Qualitative selective enrichment) | ||
Clostridium botulinum; Clostridium perfringens (including spores of sulfite reducing Clostridia); Enterococci; Escherichia coli; Listeria spp.; Pseudomonas aeruginosa; Staphylococcus spp. - Coagulase producing strains; Coliforms - Thermotolerant and total; Plate count; Yeasts and moulds | Membrane filter | in-house methods WTS003F, WTS004F, WTS001F, WTS011, WTS013F, WTS007, WTS005.1F and WTS006 | ||
Plate count | Pour plate | in-house method WTS001 | ||
Enterococci; Escherichia coli; Streptococcus - Faecal; Coliforms - Thermotolerant and total | Most probable number (MPN) | in-house methods WTS003 and WTS004 | ||
Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Purified and processed waters; Swimming pool and spa waters | Campylobacter jejuni; Salmonella spp.; Vibrio cholerae; Vibrio parahaemolyticus; Vibrio spp.; Vibrio vulnificus | Qualitative selective enrichment | in-house methods WTS010, WTS009 and WTS008 | |
Potable waters | Bacillus anthracis; Campylobacter jejuni; Clostridium botulinum; Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145; Escherichia coli; Escherichia coli O157; Listeria spp.; Salmonella spp.; Vibrio cholerae; Vibrio parahaemolyticus; Vibrio spp.; Vibrio vulnificus | Most probable number (MPN); Qualitative selective enrichment | in-house methods FDS025, FDS031, FDS004 (MPN), FDS004M, FDS037, WTS007, WTS008, WTS009 and WTS010 | |
Potable waters; Soils | Salmonella spp. | Enzyme linked immunosorbent assay (ELISA) - Automated (VIDAS) | in-house method FDS040 | |
Powder of unknown composition; Soils | Bacillus anthracis | Qualitative selective enrichment | in-house method FDS031 | |
Soils | Legionella spp. | Spread plate | in-house method WLS002 | |
Salmonella spp. | Qualitative selective enrichment | in-house method FDS036 | ||
Surfaces | Listeria spp.; Salmonella spp. | PCR - Real time | AFNOR BRD 07/06-07/04 (in-house method FDS050); AFNOR BRD 07/13-05/07 (in-house method FDS051); | |
Analysis for toxins | Air - Ambient; Air - Confined spaces; Air - Indoor; Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Potable waters; Powder of unknown composition; Purified and processed waters; Soils; Surfaces; Swimming pool and spa waters | Ricin | Immunochromatography | in-house method CRS007 |
Air - Ambient; Air - Confined spaces; Air - Indoor; Estuarine waters; Fresh waters; Industrial waters - Treated, recirculating; Marine waters; Purified and processed waters; Soils; Swimming pool and spa waters | Clostridium botulinum toxin | Bioassay - Mouse | in-house methods FDS025 and RFS017 | |
Clostridium botulinum toxin | Polymerase chain reaction (PCR) | in-house method MMS058 | ||
Challenge testing | Potable waters | Bacteria; Moulds; Yeasts | Cultural; Membrane filter; Most probable number (MPN); Pour plate; Qualitative selective enrichment; Spread plate - Aerobic and anaerobic; Streak plate | in-house methods CHS001, CHS002, IMS001 and IMS002 |
Legal management - Forensic operations module | Materials defined by all or some for which the site is accredited | Case record review; Chain of custody; Control of records; Court testimony monitoring; Sample/evidence integrity; Security and access | To be determined | |
Molecular analysis - Bioinformatic analysis and interpretation | Bacterial isolates; DNA sequences | Single nucleotide polymorphism (SNP) interpretation | Bioinformatics pipeline | In-house method MMS147 |
Molecular analysis - Sequencing | Bacterial isolates | Antimicrobial resistance gene, mutation detection and inference of resistance | Whole genome sequencing | in-house method MMS184 |
Listeria monocytogenes serotyping | Whole genome sequencing | in-house method MMS126 | ||
Single nucleotide polymorphism (SNP) detection | Whole genome sequencing | In-house method MMS147 | ||
Salmonella spp. serotyping | Whole genome sequencing | In-house method MMS136 | ||
Antimicrobial resistance genes | Whole genome sequencing | In-house method MMS118 | ||
Escherichia coli serotyping | Whole genome sequencing | In-house method MMS130 | ||
Extracted DNA | Sequencing | Sanger sequencing | in-house method MMS012 | |
Sequencing | Massively parallel sequencing (MPS) | in-house method MMS103 | ||
Sequencing | Multilocus sequence typing (MLST) | in-house method MMS109 | ||
Public health investigation | Filters; Potable waters; Powder of unknown composition; Product contact surfaces; Sediments; Sludges; Soils; Textiles; Waters | Organisms of public health significance | Techniques defined by all or some for which the site is accredited | in-house methods IMS001 and IMS002 |
ISO/IEC 17025 (2017)
Food and Beverage
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Analysis for microorganisms | Bacterial isolates | Bacillus anthracis virulence factor genes; Campylobacter coli; Campylobacter jejuni; Campylobacter spp.; Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145; Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145 stx; Escherichia coli O157 H7; EAE genes and O-antigen specific genes; Shiga toxin 1 (Stx1); Shiga toxin 2 (Stx2); Virulence factor - Enterohaemolysin; Virulence factor - Intimin | Polymerase chain reaction (PCR) | in-house methods MMS025 and MMS100 |
Clostridium botulinum; Clostridium botulinum toxin | Polymerase chain reaction (PCR) | in-house methods MMS058 | ||
Identification | MALDI-TOF | in-house method MSS001, software version V3.2 | ||
Bacillus anthracis | Polymerase chain reaction (PCR) | in-house method MMS025 and MMS058 | ||
Bacillus anthracis | Qualitative selective enrichment | in-house method FDS031 | ||
Beverages; Cereal products; Confectionery; Crustaceans; Dairy products; Edible fats and oils; Eggs and egg products; Fish; Food additives; Food packaging; Fruit and fruit products; Gelatine and other gums; Heat-processed foods in hermetically sealed containers; Herbs and spices; Honey; Meat and meat products; Mixed foods; Molluscs (including shell); Nutritional supplements; Nuts and nut products; Poultry and poultry products; Sugar and sugar products; Vegetables and vegetable products | Listeria spp.; Salmonella spp. | PCR - Real time | AFNOR BRD 07/06-07/04 (in-house method FDS050); AFNOR BRD 07/13-05/07 (in-house method FDS051); | |
Beverages; Cereal products; Confectionery; Crustaceans; Dairy products; Edible fats and oils; Eggs and egg products; Fish; Food additives; Fruit and fruit products; Gelatine and other gums; Heat-processed foods in hermetically sealed containers; Herbs and spices; Honey; Meat and meat products; Mixed foods; Molluscs (including shell); Nutritional supplements; Nuts and nut products; Poultry and poultry products; Sugar products; Vegetables and vegetable products | Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145; Escherichia coli; Escherichia coli O157 H7 | Serotyping | in-house methods FDS046 (FDA BAM 4A(K)) | |
Salmonella spp. | Serotyping | in-house methods ENS005 | ||
Bacillus anthracis | Microscopic examination; Streak plate | in-house method CRS003 | ||
Bacillus anthracis; Spores | Microscopic examination; Microscopy and staining | in-house method CRS002 | ||
Escherichia coli; Vibrio cholerae; Vibrio parahaemolyticus; Vibrio vulnificus; Coliforms - Thermotolerant and total | Most probable number (MPN) | in-house methods FDS003, FDS004, FDS009 | ||
Campylobacter coli; Campylobacter jejuni; Campylobacter spp.; Salmonella spp. | Biochemical | in-house methods CAS002 and ENS003 | ||
Enterobacteriaceae; Plate count | Pour plate | in-house methods FDS015M and FDS002 | ||
Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145 | Immunomagnetic concentration; Latex agglutination; Qualitative selective enrichment; Serotyping | in-house methods FDS047, FDS044 and FDS004M | ||
Clostridium botulinum toxin | Cultural; Qualitative selective enrichment | in-house methods FDS025 | ||
Listeria grayi; Listeria innocua; Listeria ivanovi; Listeria monocytogenes; Listeria murrayi; Listeria seeligeri; Listeria spp.; Listeria welshimeri; Salmonella spp. | Enzyme linked immunosorbent assay (ELISA) - Automated (VIDAS) | in-house method FDS040 (Salmonella) and FDS045 | ||
Sterility | Pour plate; Qualitative selective enrichment; Spread plate | in-house methods IMS001, IMS002 and FDS002 | ||
Bacillus anthracis; Bacillus cereus; Campylobacter coli; Campylobacter jejuni; Campylobacter spp.; Clostridium botulinum; Clostridium botulinum toxin; Cronobacter sakazakii (Enterobacter sakazakii); Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145; Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145 stx; Escherichia coli; Escherichia coli O157 H7; Listeria grayi; Listeria innocua; Listeria ivanovi; Listeria monocytogenes; Listeria murrayi; Listeria seeligeri; Listeria spp.; Salmonella spp.; Vibrio cholerae; Vibrio parahaemolyticus; Vibrio spp.; Vibrio vulnificus; Yersinia enterocolitica; Yersinia spp. | Qualitative selective enrichment | in-house methods FDS004M, FDS006E, FDS011, FDS025, FDS029, FDS031, FDS032, FDS036, FDS037, FDS042 and RFS017 | ||
Clostridium botulinum toxin | Bioassay - Mouse; Cultural; MALDI-TOF; Qualitative selective enrichment | in-house methods RFS017 | ||
Bacillus cereus; Brochothrix thermosphacta; Clostridium perfringens; Listeria grayi; Listeria innocua; Listeria ivanovi; Listeria monocytogenes; Listeria murrayi; Listeria seeligeri; Listeria spp.; Listeria welshimeri; Staphylococcus spp. - Coagulase producing strains; Vibrio cholerae; Vibrio parahaemolyticus; Vibrio spp.; Vibrio vulnificus; Yeasts and moulds | Spread plate | in-house methods FDS016, FDS006, FDS006M, FDS033, FDS008, FDS008M, FDS038, FDS005, FDS005M and FDS009M | ||
Escherichia coli - Pathogenic | Cultural; Enrichment; Immunomagnetic concentration | in-house methods ECS001, FDS004M, FDS044, FDS047 | ||
Staphylococcus enterotoxins | Enzyme linked immunosorbent assay (ELISA) - Automated (VIDAS) | in-house method FDS043 (AOAC 2007.06) | ||
Ricin | Immunochromatography | in-house method CRS007 | ||
Escherichia coli non O157 STEC serogroups O26, O45, O103, O111, O121, O145; Escherichia coli O157 H7; Escherichia coli stx and ehxA genes | Biochemical; Cultural; Immunomagnetic concentration; Latex agglutination; MALDI-TOF; Qualitative selective enrichment | in-house methods FDS004M, FDS047 | ||
Beverages; Cereal products; Confectionery; Crustaceans; Dairy products; Edible fats and oils; Eggs and egg products; Fish; Food additives; Fruit and fruit products; Gelatine and other gums; Heat-processed foods in hermetically sealed containers; Herbs and spices; Honey; Meat and meat products; Mixed foods; Molluscs (including shell); Nutritional supplements; Nuts and nut products; Poultry and poultry products; Sugar products; Vegetables and vegetable products; Waters for domestic purposes | Vibrio cholerae; Vibrio parahaemolyticus; Vibrio spp.; Vibrio vulnificus | Cultural; Serotyping; Slide agglutination | in-house methods ENS033 | |
Analysis for toxins | Bacterial isolates | Clostridium botulinum toxin | Polymerase chain reaction (PCR) | in-house method MMS058 |
Shiga toxin 1 (Stx1); Shiga toxin 2 (Stx2); Virulence factor - Enterohaemolysin; Virulence factor - Intimin | Polymerase chain reaction (PCR) | in-house methods MMS025 and MMS100 | ||
Beverages; Cereal products; Confectionery; Crustaceans; Dairy products; Edible fats and oils; Eggs and egg products; Fish; Food additives; Fruit and fruit products; Gelatine and other gums; Heat-processed foods in hermetically sealed containers; Herbs and spices; Honey; Meat and meat products; Mixed foods; Molluscs (including shell); Nutritional supplements; Nuts and nut products; Poultry and poultry products; Sugar products; Vegetables and vegetable products | Clostridium botulinum toxin | Bioassay - Mouse | in-house methods FDS025 and RFS017 | |
Ricin | Immunochromatography | in-house method CRS007 | ||
Analysis of physical and nutritional characteristics | Beverages; Cereal products; Confectionery; Crustacean products; Dairy products; Edible fats; Eggs and egg products; Fish; Food additives; Fruit and fruit products; Gelatine and other gums; Heat-processed foods in hermetically sealed containers; Herbs; Honey; Meat and meat products; Mixed foods; Molluscs (including shell); Nutritional supplements; Nuts and nut products; Poultry and poultry products; Spices; Sugar and sugar products; Vegetable products; Vegetables | Water activity; pH | Electrometric | in-house methods FDS019 and FDS020 |
Challenge testing | Beverages; Foods; Product contact surfaces | Bacteria; Moulds; Yeasts | Cultural; Membrane filter; Most probable number (MPN); Pour plate; Qualitative selective enrichment; Spread plate - Aerobic and anaerobic; Streak plate | in-house methods CHS001, CHS002, IMS001 and IMS002 |
Detection, characterisation and/or quantification of nucleic acids - Enteric viruses | Fruit and fruit products; Vegetables and vegetable products | Hepatitis A virus (HAV) | PCR - Real time | ISO 15216-2 (in-house method FDS049, MMS090) |
Legal management - Forensic operations module | Materials defined by all or some for which the site is accredited | Case record review; Chain of custody; Control of records; Court testimony monitoring; Sample/evidence integrity; Security and access | To be determined | |
Molecular analysis - Bioinformatic analysis and interpretation | Bacterial isolates; DNA sequences | Single nucleotide polymorphism (SNP) interpretation | Bioinformatics pipeline | In-house method MMS147 |
Molecular analysis - Sequencing | Bacterial isolates | Listeria monocytogenes serotyping | Whole genome sequencing | in-house method MMS126 |
Antimicrobial resistance gene, mutation detection and inference of resistance | Whole genome sequencing | in-house method MMS184 | ||
Escherichia coli serotyping | Whole genome sequencing | In-house method MMS130 | ||
Single nucleotide polymorphism (SNP) detection | Whole genome sequencing | In-house method MMS147 | ||
Salmonella spp. serotyping | Whole genome sequencing | In-house method MMS136 | ||
Antimicrobial resistance genes | Whole genome sequencing | In-house method MMS118 | ||
Extracted DNA | Sequencing | Massively parallel sequencing (MPS) | in-house method MMS103 | |
Sequencing | Sanger sequencing | in-house method MMS012 | ||
Sequencing | Multilocus sequence typing (MLST) | in-house method MMS109 | ||
Public health investigation | Beverages; Food packaging; Foods; Product contact surfaces | Organisms of public health significance | Techniques defined by all or some for which the site is accredited | in-house methods IMS001 and IMS002 |
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Analysis for microorganisms | Bacterial isolates | Identification | MALDI-TOF | in-house method MSS001, software version V3.2 |
Legal management - Forensic operations module | Materials defined by all or some for which the site is accredited | Case record review; Chain of custody; Control of records; Court testimony monitoring; Sample/evidence integrity; Security and access | ||
Molecular analysis - Bioinformatic analysis and interpretation | Bacterial isolates; DNA sequences | Single nucleotide polymorphism (SNP) interpretation | Bioinformatics pipeline | In-house method MMS147 |
Molecular analysis - Sequencing | Bacterial isolates | Antimicrobial resistance gene, mutation detection and inference of resistance | Whole genome sequencing | in-house method MMS184 |
Listeria monocytogenes serotyping | Whole genome sequencing | in-house method MMS126 | ||
Antimicrobial resistance genes | Whole genome sequencing | In-house method MMS118 | ||
Salmonella spp. serotyping | Whole genome sequencing | In-house method MMS136 | ||
Escherichia coli serotyping | Whole genome sequencing | In-house method MMS130 | ||
Single nucleotide polymorphism (SNP) detection | Whole genome sequencing | In-house method MMS147 | ||
Extracted DNA | DNA screening for naturally occurring genetic elements; Sequencing | Massively parallel sequencing (MPS) | in-house method MMS103 | |
Allele typing; Sequencing | Multilocus sequence typing (MLST) | in-house method MMS109 | ||
DNA screening for naturally occurring genetic elements; Sequencing | Sanger sequencing | in-house method MMS012 | ||
Public health investigation | Clinical specimens; Medical devices; Packaging materials | Organisms of public health significance | Techniques defined by all or some for which the site is accredited | in-house methods IMS001 and IMS002 |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
1019
Site No.
1012
Print date
01 Sep 2024